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Abstract  21 
Background and Purpose: Offspring exposed to maternal diabetes are at increased risk of neurocognitive 22 
impairment but origins of this are unknown. Using 3 tesla (T) MRI, we investigated the feasibility of 23 
comprehensive assessment of brain metabolism (1HMRS), micro- (DWI) and macro-structure (sMRI) in the 24 
third trimester fetus in women with diabetes and to determine normal ranges for the MRI parameters 25 
measured.  26 
Materials and Methods: Women with singleton pregnancy with diabetes (n=26) and healthy controls (n=26) 27 
were recruited prospectively for MRI studies between 34-38 weeks gestation.   28 
Results: Data suitable for post-processing was obtained from 79%, 71% and 46% of women for 1HMRS, DWI 29 
and sMRI, respectively. There was no difference in the NAA/Cho and NAA/Cre ratios in the fetal brain in 30 
women with diabetes compared to controls (1.74 (0.79) vs 1.79 (0.64) p=0.81, and 0.78 (0.28) vs 0.94 (0.36) 31 
p=0.12, respectively) but the Cho/Cre ratio was marginally lower (0.46 (0.11) vs 0.53 (0.10) p=0.04). There 32 
was no difference in mean anterior white, posterior white and deep grey matter ADC between cases and 33 
controls (1.16 (0.12) vs 1.16 (0.08) p=0.96, 1.54 (0.16) vs 1.59 (0.20) p=0.56 and 1.49 (0.23) vs 1.52 (0.23) 34 
p=0.89, respectively) or volume of the cerebrum (cc3) (243.0 (22.7) vs 253.8 (31.6), p=0.38). 35 
Conclusion: Acquiring multi-modal MRI of fetal brain at 3T from pregnant women with diabetes is feasible. 36 
Further study of fetal brain metabolism in maternal diabetes is warranted.  37 
 38 
  39 
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T1DM  Type 1 diabetes mellitus 41 
T2DM  Type 2 diabetes mellitus 42 
GDM  Gestational diabetes 43 
DWI  diffusion weighted imaging 44 
sMRI  structural magnetic resonance imaging 45 
IQR  interquartile range 46 
  47 
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Diabetes is the most common medical disorder of pregnancy with the prevalence of type 1 (T1DM), type 2  49 
(T2DM) and gestational (GDM) diabetes all increasing among women of childbearing age in resource rich 50 
settings. The perinatal complications of maternal diabetes, which reflect altered metabolic function in utero, 51 
include major congenital malformations, macrosomia, and stillbirth [1]. Long term, children born to mothers 52 
with diabetes are at increased risk for cognitive impairment [2, 3], inattentiveness [4], impaired working 53 
memory [5], and altered language development [6]. These adverse outcomes are not fully explained by 54 
postnatal events, which focuses research attention on vulnerability of the developing brain during fetal life. 55 
Identification of the nature and timing of alterations to brain structure and function that underlie neurocognitive 56 
impairment could help the development of strategies to designed to improve the long-term outcome of children 57 
of diabetic mothers. 58 
During fetal life the predominant source of brain energy is glucose, which crosses the placenta by facilitated 59 
diffusion [7]. While severe perturbations in glucose homeostasis after birth are associated with neonatal brain 60 
injury, the effect of chronic fluctuant glucose concentration experienced by fetsuses of women with diabetes on 61 
in utero brain development has not been investigated. Maternal diabetes is also associated with disturbances 62 
in fatty acid metabolism: umbilical venous blood docosahexaenoic acid concentration is reduced, which 63 
reflects lower docosahexaenoic acid transfer to the fetus [8]. Docosahexaenoic acid accumulates in the brain 64 
in abundance from the third trimester and is essential for neurogenesis, neurotransmission and protection from 65 
oxidative stress. Reduced bioavailability of this key metabolite has been suggested as a putative mechanism 66 
for programming altered neurodevelopment [8, 9].  67 
Advances in proton magnetic resonance spectroscopy (1HMRS), and diffusion weighted and structural 68 
magnetic resonance imaging (DWI, sMRI) have led to the development of objective and sensitive measures of 69 
fetal brain structure and metabolism. Use of these technologies has revealed alterations in cerebral 70 
NAA:choline ratio and gyrification in fetuses with congenital heart disease [10], temporal lobe volumes in 71 
fetuses with congenital cytomegalovirus infection [11], and ADC values and parenchymal volume in antenatal 72 
ventriculomegaly [12, 13]. Historically, the majority of fetal imaging studies have been undertaken at 1.5T. 73 
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However, although an increasing number of studies have been performed at 3T field strength [14-20] which 74 
has benefits over 1.5 T due to improved signal-to-noise and is likely to be advantageous for depicting fetal 75 
anatomy [21], to date there have been no studies assessing the feasibility of recruiting women with diabetes 76 
for fetal neuroimaging.  77 
Early life metrics derived from 1HMRS, DWI and sMRI are associated with function in childhood. After preterm 78 
birth, NAA/Cho and Cho/Cr ratios are associated with neurodevelopmental outcome at age 2 [22], lactate/NAA 79 
predicts outcome following hypoxic ischaemic encephalopathy [23] and abnormalities in the NAA/Cre and 80 
Cho/Cre ratios in neonates [24] and older children [25] predict developmental delay. Increased ADC values in 81 
white matter are associated with diffuse white matter injury following preterm birth [26] and with poor outcome 82 
after hypoxic ischaemic encephalopathy in term infants [27, 28]. Finally, reduced regional and whole brain 83 
volumes, are associated with specific preterm comorbidities [29, 30] and structural alteration predicts long term 84 
impairment after preterm birth [31, 32] 85 
Based on disturbances to fetal glucose and fatty acid metabolism associated with maternal diabetes and the 86 
neurocognitive profile of offspring, we aimed to investigate the feasibility of comprehensive fetal brain 87 
assessment by acquiring measurements of NAA/Cho, NAA/Cre and Cho/Cre ratios, regional apparent 88 
diffusion coefficient (ADC) measurements and volume of the cerebrum during the third trimester of pregnancy 89 
from women with diabetes, and from healthy controls using 3T MRI. The secondary aim was to determine 90 
normal values for these measures for future studies designed to investigate the effect of maternal disease of 91 




Study population 96 
Ethical approval was obtained from the National Research Ethics Committee (South East Scotland Research 97 
Ethics Committee) and written informed consent was obtained. Women with a pregnancy complicated by 98 
diabetes (n=26) and healthy controls (n=26) were recruited prospectively from antenatal diabetes clinics at the 99 
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Simpson Centre for Reproductive Health at the Royal Infirmary, Edinburgh, UK. The inclusion criteria were a 100 
singleton pregnancy and normal fetal anomaly scan at 20 weeks gestation. Women with diabetes were eligible 101 
to participate if they had gestational diabetes, diagnosed using the Scottish Intercollegiate Guideline Network 102 
diagnostic criteria [33] as a fasting venous plasma glucose of ≥ 5.1mmol/l or two hour glucose of ≥ 8.5mmol/l 103 
after a 75 g oral glucose tolerance test or pre-gestational type 1 or type 2 diabetes. Exclusion criteria were: 104 
significant co-existing maternal systemic disease other than maternal diabetes, and women with any contra-105 
indications to MRI including metal implants and pacemakers.   106 
 107 
MR image acquisition 108 
Magnetic resonance studies were performed at the Clinical Research Imaging Centre in the Queen’s Medical 109 
Research Institute, University of Edinburgh, UK using a Siemens Magnetom Verio 3T MRI clinical scanner 110 
(Siemens Healthcare GmbH, Erlangen, Germany). To avoid vena-cava compression, women were placed in a 111 
left-lateral tilt, with blood pressure being constantly monitored using a Veris MRI Vital Signs Monitor (Medrad, 112 
Bayer, UK). No fetal sedation was used, women were limited to spending 45 minutes in the scanner and data 113 
were acquired with women free breathing throughout. MRI scans were performed between 34 – 38 weeks 114 
gestation. A radiologist with experience in MRI reported all images. 115 
  116 
T2 weighted half-Fourier acquisition single-shot turbo spin-echo images were acquired of the fetal brain in 117 
sagittal, coronal and transverse orientations (HASTE: TR/TE = 1800/86ms, FOV = 400 x 400mm, matrix = 192 118 
(phase) x 256 (frequency), slice thickness = 8mm, acquisition time = 18 s).  These images were used to plan 119 
the position of the single 20 mm3 spectroscopy voxel within the fetal brain. The scanner bed was moved to 120 
ensure that the fetal brain was positioned at the isocentre and the voxel was positioned within one hemisphere 121 
of the fetal brain, avoiding ventricles and contaminant signal from surrounding tissue. An optimised semi-122 
automated shimming protocol was systematically applied until the full width at half-maximum of the water peak 123 
was less than 20 Hz. A single-voxel point-resolved spectroscopy technique was applied with 124 
TR/TE = 1500 ms/30 ms, 96 signal averages, bandwidth of 2000 Hz and a water suppression bandwidth of 125 
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50 Hz. The spectral acquisition took 2 min 30 s. Signal was received from selected elements of the spine 126 
matrix coil and body matrix surface coils positioned to allow adequate coverage of the fetal brain. A post-127 
spectroscopy 3-plane HASTE acquisition was then compared with the pre-spectroscopy HASTE images to 128 
allow visual assessment of fetal movement during the spectral acquisition.  If the expert operator observed 129 
evidence of significant movement between HASTE acquisitions then the spectroscopy voxel was repositioned 130 
and the spectral acquisition was repeated. No additional filtering or quality-control limiting of data was applied 131 
during the processing stage. We therefore processed all of the MRS data that was acquired. An example of 132 
voxel positioning for MRS acquisition is shown in Fig. 1a.  133 
 134 
Transverse DWI of the whole fetal brain (TR/TE =7300/106ms, FOV=400 × 400mm, matrix = 128 × 128, slice 135 
thickness = 3mm, b-values = 0, 500 and 1000 s/mm2) were acquired. DWI were checked at point of acquisition 136 
for obvious signs of fetal motion, and repeated if required. ADC maps were generated automatically from the 137 
diffusion weighted images.  138 
 139 
Finally, additional transverse HASTE images were acquired with identical coverage to the DW images to aid 140 
subsequent ROI analysis and to enable construction of the 3D motion-corrected brain volumes.  141 
 142 
Data analysis: 1HMRS  143 
Spectral analysis was carried out using the QUEST algorithm available in jMRUI [34]. This technique 144 
estimates metabolite amplitudes using a non-linear least squares fit of simulated metabolite signals to the 145 
acquired spectrum. A metabolite basis set was generated using the NMR-Scope function available in jMRUI 146 
[35] and included contributions from NAA (2.01, 2.49 and 2.70 ppm), Cho (3.2, 3.53 and 4.08ppm) and Cre 147 
(3.04 and 3.93 ppm). The following ratios were then calculated: NAA/Cho, NAA/Cre and Cho/Cre [36, 37]. The 148 
Quest algorithm calculates errors associated with the estimated metabolite amplitudes using an extended 149 
version of the Cramor-Rao lower bounds calculation [35]. The errors for each of the calculated metabolite 150 
ratios were derived through error propagation of the jMRUI output.  151 
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Data analysis: diffusion and structural MRI  153 
(i) Apparent Diffusion Coefficients 154 
Region of interest (ROI) analysis was carried out on ADC maps using standard software on the 3 T MR 155 
Siemens Magnetom Verio system. First, ROIs within white matter and grey matter were identified from the 156 
HASTE images acquired in the same plane and with the same coverage as the diffusion weighted images. A 157 
slice above the ventricles was identified as white matter and a slice at the level of the thalami was identified as 158 
deep grey matter using landmarks described in Boardman et al [38]. The identical slices were then identified 159 
on the corresponding ADC map; 4 ROIs were positioned in the white matter (2 posterior and 2 anterior) and 2 160 
were positioned in the grey matter. Due to differences in fetal brain volume an anatomically appropriate ROI 161 
size was used for each individual brain, taking care to avoid partial volume effects from adjacent structures 162 
and artefacts. The mean (standard deviation, SD) ADC value for each ROI was recorded. The mean (SD) 163 
white matter ROI size was 0.30±0.12 and mean grey matter ROI size was 0.32±0.13. Example ROI 164 
placements for white and grey matter are shown in Figure 1b. Inter-rater agreement was checked by two 165 
independent investigators (DA, GM).  166 
 167 
(ii) Structural MRI 168 
For each participant, a single 3D motion-corrected brain volume was reconstructed using a slice-to-volume 169 
registration method [39] (Figure 1c). The fetal brain was extracted from surrounding fetal and maternal tissue 170 
using an atlas-based approach [40]. All reconstructed images were non-linearly aligned to the closest age-171 
matched template from a publically available 4D fetal brain atlas [41]. Then, an automatic method based on an 172 
Expectation-Maximisation framework for brain tissue segmentation was used, where the priors of brain tissues 173 
were propagated using prior probabilities provided by the 4D atlas. Finally, binary masks of the cerebrum 174 
(intracranial contents excluding intraventricular CSF, extra-axial CSF, choroid plexus, brainstem, cerebellum 175 
and pons structures) and the intracranial volume (GM, WM and CSF) were deformed to the subject’s native 176 
space, and volumes were calculated. 177 
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Statistical analysis 179 
This was a feasibility study so a formal power calculation for sample size was not required [42, 43]. For 180 
normally distributed data, mean and SD are reported and for non-normally distributed data, the median and 181 
interquartile range (IQR) are reported. For group-wise comparisons of normally distributed variables 182 
independent sample t-test was used, and for skewed data the Mann-Whitney U test was used. To analyse 183 
regional ADC values, we first tested for evidence of laterality in anterior and posterior white matter, and deep 184 
grey matter values using paired samples t-test, and if there were no significant difference between left and 185 
right the values were averaged to compute mean anterior white matter ADC, mean posterior white ADC and 186 
mean deep grey matter ADC per individual. The distributions were assessed for normality, and independent 187 
samples t-test was used for group-wise comparisons of regional ADC. Inter-observer agreement in ADC 188 
measurements was assessed for each region in a randomly selected subset of 20 participants using Bland-189 
Altman statistics. For group-wise analysis of NAA/Cho, NAA/Cre and Cho/Cre ratios, cerebrum volume and 190 
intracranial volume, independent samples t-test was used after assessing for equality of variance between 191 
groups. Statistical analyses were performed using SPSS 21 (SPSS Inc, Chicago, IL) with statistical significant 192 
defined as p<0.05.  193 
 194 
Results  195 
 196 
Participants 197 
The maternal demographics and delivery outcomes of the study population are demonstrated in Table 1. All 198 
women tolerated the MRI scan well and no scan had to be abandoned due to maternal discomfort or 199 
claustrophobia. Of the women with diabetes, thirteen were diagnosed with GDM during pregnancy, twelve had 200 
T1DM and one had T2DM. In women with GDM, the median (range) gestation at diagnosis and diagnosis to 201 
scan interval was 27.1 weeks (12.0  - 31.0) and 8.9 weeks (4.4 – 23.6 ), respectively. Only one woman with 202 
GDM was treated with diet alone. The other twelve were treated with metformin (n=9) or metformin and insulin 203 
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(n=3) to achieve glycaemic control. All women with T1DM were insulin-treated and the one woman with T2DM 204 
was treated with insulin and metformin. The HbA1c (glycolated haemoglobin) at booking for women with T1DM 205 
and T2DM was 51.9 (16.6) mmol/mol. Two women with GDM, four women with T1DM and one control had 206 
antenatal steroids for fetal lung maturation prior to MRI. Three babies of women with T1DM were admitted to 207 
the neonatal unit for less than 72 hours. The reasons for admission were suspected sepsis (culture negative) 208 
and transient low blood glucose (n=1), a fractured clavicle sustained during a forceps delivery with shoulder 209 
dystocia and a duplication cyst that was not diagnosed antenatally. No babies born to healthy controls required 210 
admission. All babies were discharged home alive and well. 211 
 212 
There was no difference in the gestation in weeks at MRI between women with diabetes and healthy controls 213 
(36.0 (0.8) vs 36.1 (0.9), p=0.69). No adjustment was therefore made for gestational age in the statistical 214 
analysis. No congenital anomalies, acquired brain injuries or incidental findings were detected by MRI.  215 
 216 
MR spectroscopy  217 
In utero 1HMRS of the fetal brain of suitable quality for analysis was obtained in 41/52 (79%) of the study 218 
population [22/26 (85%) women with diabetes, 19/26 (73%) healthy controls. There was no difference in the 219 
clinical characteristics of women in whom interpretable data was acquired compared to those in whom it was 220 
not (data not shown). There was no difference in the NAA/Cho and NAA/Cre ratios in the fetal brain in women 221 
with diabetes compared to controls (1.74 (0.70) vs 1.79 (0.64) p=0.81, and 0.78 (0.28) vs 0.94 (0.36) p=0.12, 222 
respectively). The Cho/Cre ratio was marginally lower in the fetal brain in women with diabetes compared to 223 
controls (0.46 (0.11) vs 0.53 (0.10) p=0.04) (Figure 2). 224 
 225 
Diffusion weighted imaging - ADC 226 
DWI amenable to ADC computation were available for 37/52 (71%) of the study population (18/26 (69%) 227 
women with diabetes, 19/26 (73%) healthy controls). Fetal motion or maternal size prevented interpretable 228 
data being obtained from 9/52 (17%) of the study population. There was no difference in the clinical 229 
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characteristics of women in whom interpretable data was acquired compared to those in whom it was not (data 230 
not shown).  231 
 232 
There was no evidence of laterality in the anterior white matter, posterior white matter or deep grey matter 233 
ADC values (all p>0.05). Data were therefore combined to three variables – mean anterior white matter, mean 234 
posterior white matter and mean deep grey matter ADC. There was no difference in mean (SD) ADC values 235 
for anterior white matter, posterior white matter and deep grey matter in women with DM compared to controls 236 
(1.16 (0.12) vs 1.16 (0.08) p=0.96, 1.54 (0.16) vs 1.59 (0.20) p=0.56 and 1.49 (0.23) vs 1.52 (0.23) p=0.89, 237 
respectively) (Figure 3).  238 
 239 
There was good inter-rater agreement between the two independent investigators for ADC values. The mean 240 
difference and 95% confidence intervals between investigators for anterior white matter, posterior white matter 241 
and deep grey matter measurements are reported in Table 2.  242 
 243 
Brain volumes 244 
Tissue segmentation data suitable for analysis was used to assess the macrostructure of the fetal brain in 245 
24/52 (46%) of the study population [9/26 (35%) women with diabetes, 15/26 (58%) healthy controls]. Fetal 246 
motion or data quality prevented interpretable data being obtained from 28/52 (54%) of the study population. 247 
There was no difference in cerebrum volume /cc3 (sd) in women with diabetes compared to controls (243.0cc3 248 
(22.7) vs 253.8cc3 (31.6), p=0.39). There was no difference in intracranial volume in fetuses of women with 249 




In this study we demonstrated that it is feasible to recruit pregnant women with diabetes to undergo MRI at 3T 254 
during the third trimester of pregnancy for measurements of NAA/Cho, NAA/Cre and Cho/Cre ratios, regional 255 
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ADC measurements and cerebrum and intracranial volumes. We chose to acquire 1HMRS, DWI and sMRI 256 
because of their use as markers of tissue injury / altered metabolism in the newborn period and their 257 
relationships with long term outcome. The values we acquired contribute useful normative data for future fetal 258 
brain studies carried out using 3T systems.  259 
 260 
Although this feasibility study was not powered to detect group differences, we observed a marginal but 261 
significant reduction in Cho/Cre in the brains of fetuses of diabetic mothers during the third trimester. The MR 262 
spectroscopy choline peak includes free choline, phosphocholine, and glycerophosphocholine, so these data 263 
raise the possibility that brain metabolism and neuronal membrane phospholipid turn-over are altered in 264 
pregnancies with diabetes. While this finding requires confirmation in a larger study, it is notable that 265 
alterations in the Cho/Cre ratio in brains of adults with Type 2 diabetes have been reported [44]. 266 
 267 
A strength of our study is that we recruited a cohort of women with well-characterized diabetes with all 268 
participants being scanned within a four-week time window and gestation matched to our control group. This is 269 
important because 1HMRS spectra and ADC values are dynamic during this period of brain development [45-270 
47]. We also acquired sMRI suitable for conventional clinical reporting was available for all participants. A 271 
limitation of our study is that we were unable to acquire data amenable to quantitative analysis from on all 272 
fetus’ scanned. Despite ensuring comfort of the women in a large bore scanner, data could not be processed 273 
from 1HMRS in 21% of cases, DWI in 29% of cases and sMRI in 54% of cases. The low data yield for sMRI 274 
was partly because acquisition of 1HMRS and DWI was prioritized over sMRI.  For future study designs that 275 
require fetal brain segmentation, yield may be increased by modifications to the acquisition protocol such as 276 
increasing the number of stacks per plane, accepting that time constraints required for safety may curtail other 277 
acquisitions (we capped imaging at 45 minutes). Of note, sMRI suitable for conventional clinical reporting was 278 
available for all participants.  279 
 280 
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We chose to recruit a heterogeneous population of women with diabetes to assess the feasibility of dissecting 281 
the effect of different in utero exposure to T1DM, T2DM and GDM in a future study. Recruitment of women 282 
with T1DM and GDM was relatively easy, thus recruitment to a future study assessing the effect of in utero 283 
exposure of T1DM and GDM on the fetal brain would be feasible. In contrast, we were only able to recruit one 284 
woman with T2DM, due to the lower prevalence of this condition. Thus, targeting recruitment of women with 285 
T2DM to a future study will not be practical unless recruitment occurred across multiple sites.  286 
 287 
Our data were acquired using a 3 T system as opposed to a 1.5 T. For the advanced imaging techniques used 288 
in this study, there are advantages of acquiring data using the higher field strength of 3T [48]. Compared to 289 
lower field strengths, imaging at higher field strengths increases the signal-to-noise ratio. This improves the 290 
spectral quality obtained in 1HMRS and the ability to differentiate between closely located metabolites, 291 
particularly at short echo times. Inability to complete data acquisition within the time available due to fetal 292 
movement is a major limitation of MRI in pregnancy. Acquiring data more rapidly by using more advanced 293 
imaging methodologies, employing methods of motion correction to compensate for fetal movement and using 294 
alternative sampling techniques such as compressed sensing are likely to significantly increase data yield in 295 
the future. Finally, one advantage of 3 T is the ability to acquire images with higher spatial resolution 296 
(depending on the imaging coil used), potentially increasing diagnostic accuracy [49].   297 
 298 
Perinatal image metrics are sensitive to tissue injury and neuroprotective treatment strategies. They are 299 
therefore increasingly used to address the ‘gap in translation’ in perinatal neuroscience to assess therapies 300 
that show promise in pre-clinical studies at lower economic and opportunity costs than randomised controlled 301 
trials powered on clinical outcomes [50]. The normative data provided here may inform the development of 302 
fetal brain biomarkers for use in interventional perinatal neuroprotective outcome studies. 303 
 304 
Conclusions  305 
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In conclusion, the data provide proof-of-concept that comprehensive assessment of fetal brain using measures 306 
derived from images acquired at 3T from women with diabetes and healthy controls is achievable. In addition 307 
they suggest that fetal brain MRS may provide a promising image marker of altered brain development in 308 
maternal diabetes. Finally, although we studied fetuses of mothers with diabetes, this research pipeline and 309 
the normative values obtained could be applied to any paradigm in which fetal origins of brain development 310 
are being investigated using 3T MRI.   311 
 312 
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Figure Legends: 451 
 452 
Figure 1:  453 
Examples of: MRS voxel placement in fetal brain (A - C), Regions of Interest for DWI in anterior white matter 454 
and posterior white matter (right and left) (E) and deep grey matter (right and left) (F), tissue segmentation in 455 
the brain with the brain highlighted in green (G - H).  456 
 457 
Figure 2:  458 
Metabolite ratios for NAA/Cho, NAA/Cr and Cho/Cr in the fetal brain in women with diabetes and healthy 459 
controls. Data presented as mean +/- standard deviation. 460 
 461 
Figure 3:  462 
ADC values in the anterior white matter, posterior white matter and deep grey matter the fetal brain in women 463 
with diabetes and healthy controls. Data presented as mean +/- standard deviation. 464 
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Table 1: Demographics, MRI details and delivery outcomes 
 











Maternal Demographics      
    Maternal age (years)1 31 (5) 31 (5) 32 (5) 30 (6) 34 
    Parity2 0 (0-3) 0 (0-3) 1 (0-2) 0 (0-3) 0 
    Current smoker3  1 (4) 3 (12) 1 (8) 2 (17)  
    Deprivation3       
 SIMD 1-3 13 (50) 13 (50) 6 (46) 6 (50) 1 
 SIMD 4-5 13 (50) 13 (50) 7 (54) 6 (50)  
      
MRI details      
Gestation at MRI (weeks)1 36.1 (0.9) 36.0 (0.8) 36.0 (0.8) 36.0 (0.9) 36.7 
MRI to delivery interval (weeks)1 3.6 (1.6) 2.1 (1.2) 2.6 (1.2) 1.6 (1.1) 15 
      
Neonatal outcome      
    Gestation delivery (weeks)1 39.7 (1.5) 38.1 (1.4) 38.6 (1.1) 37.6 (1.5) 38.9 
    Birthweight (g)1 3372 (467) 3551 (627) 3629 (483) 3508 (780) 3040 
    Sex (male: female) 13:13 9:17 6:7 2:10 Male 
    Occipito-frontal circumference (cm)1 34.4 (1.4) 34.8 (1.8) 35 (1.6) 35 (2.2) 36 
1 Mean (SD), 2 Median (range), 3 n (%), 4 SIMD Scottish Index of Multiple Deprivation, SIMD 1 most deprived, 
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Table 2: Bland Altman statistics for ADC measurements recorded by two observers. 
 
 Mean difference  Mean + (1.96*SD) Mean - (1.96*SD) 
Grey Matter ADC -0.073 × 10-3 mm2/s 0.108 × 10-3 mm2/s -0.253 × 10-3 mm2/s 
Anterior White Matter 
ADC 
-0.033 × 10-3 mm2/s 0.175 × 10-3 mm2/s -0.241 × 10-3 mm2/s 
Posterior White Matter 
ADC 
-0.028 × 10-3 mm2/s 0.225 × 10-3 mm2/s -0.281 × 10-3 mm2/s 
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